Literature DB >> 2889989

Preprandial intranasal insulin as adjuvant therapy in type II diabetics.

M el-Etr, G Slama, N Desplanque.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2889989     DOI： 10.1016/s0140-6736(87)91508-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Intranasal insulin therapy: the clinical realities.

Authors:  J Hilsted; S Madsbad; A Hvidberg; M H Rasmussen; T Krarup; H Ipsen; B Hansen; M Pedersen; R Djurup; B Oxenbøll
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

Review 2.  Intranasal insulin. Clinical pharmacokinetics.

Authors:  L Illum; S S Davis
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.